Immunophenotyping Services
Immunophenotyping is essential in the clinical phase of immune cell-based therapies as it provides detailed insights into the immune system’s response to new therapies, aiding in the evaluation of treatment efficacy and safety. By analyzing specific markers on immune cells, researchers can track the persistence, expansion, and functionality of therapeutic cells in patients. This detailed profiling supports the optimization and refinement of immune cell-based therapies, enhancing their potential for successful clinical outcomes.
Our Expertise
At Avance Biosciences, we excel in immunophenotyping services, leveraging our extensive experience and cutting-edge technology. Our use of the CytoFLEX Multicolor Flow Cytometer allows for detailed and accurate analysis of immune cell subsets, ensuring high-quality data. With years of expertise in immunological assays, we provide reliable, reproducible results that meet the stringent demands of clinical studies. Our comprehensive services encompass assay development, validation, and sample analysis, supporting your drug development process at every stage.
Immunophenotyping Services
Applications
Description
Biomarker Discovery
- Identifying immune cell subsets associated with disease severity, prognosis, or treatment response.
- Correlating immune cell profiles with clinical outcomes.
Monitoring Immune Responses
- Evaluating changes in immune cell populations during disease progression or in response to treatment.
- Assessing immune cell activation, differentiation, and functional status.
Personalized Medicine
- Tailoring treatment strategies based on individual immune profiles.
- Predicting patient responses to immunotherapies or vaccines.
What We Offer
Critical Quality Attributes
Assay
Description
Flow Cytometry
Analyzing cell surface markers and intracellular proteins using fluorescently labeled antibodies.
Quantifying and characterizing immune cell populations (e.g., T cells, B cells, NK cells) and their activation states.
Enzyme-Linked Immunosorbent Assay (ELISA)
Quantifying soluble proteins (e.g., cytokines, antibodies) in biological fluids.
Assessing immune responses by measuring cytokine levels indicative of immune activation or inflammation.
Polymerase Chain Reaction (PCR)
Amplifying and quantifying gene expression related to immune cell activation or specific immune responses.
Assessing gene expression profiles of immune cells in response to treatments or disease states.
Next-Generation Sequencing (NGS)
Profiling immune cell receptor repertoire (e.g., T-cell receptors) or gene expression.
Investigating diversity and clonality of immune cell populations, identifying potential biomarkers.